Rafael Holdings Inc (RFL)
NYSE:RFL
Want to see RFL full AI Analyst Report?
RFL Stock Chart & Stats
$1.22
-$0.03(-1.52%)
At close: 4:00 PM EST
$1.22
-$0.03(-1.52%)
Day’s Range― - ―
52-Week Range$1.12 - $3.19
Previous CloseN/A
Volume21.81K
Average Volume (3M)81.34K
Market Cap
$71.27M
Enterprise Value$10.66M
Total Cash (Recent Filing)$37.78M
Total Debt (Recent Filing)$660.00K
Price to Earnings (P/E)―
Beta0.57
Next Earnings
Jun 16, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.79
Shares Outstanding51,224,976
10 Day Avg. Volume101,467
30 Day Avg. Volume81,339
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)0.53
Price to Sales (P/S)54.22
P/FCF Ratio-2.63
Enterprise Value/Market Cap0.15
Enterprise Value/Revenue9.16
Enterprise Value/Gross Profit11.48
Enterprise Value/Ebitda-0.31
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Gross MarginsSustained ~84.5% gross margins indicate the company’s underlying holdings and products (IP/licensing or high-value services) can retain significant spread as revenues scale. Durable margin structure provides leverage to profits if revenue growth or milestone receipts materialize over months.
Conservative LeverageExtremely low debt reduces bankruptcy and refinancing risk, giving management time and optionality to fund clinical programs or real estate needs. This conservative balance sheet is a durable structural strength during extended development timelines and negative cash flow periods.
Strengthened Alzheimer’s IPAcquiring an exclusive MIT license expands patent protection for Trappsol Cyclo in a defined Alzheimer’s subgroup, a structural intellectual property enhancement. Stronger IP coverage increases long-term commercialization and partnership optionality if Phase 3/other trials produce favorable data.
Bears Say
Persistent Cash BurnSustained negative operating and free cash flow of -$13.6M TTM shows the company is consuming cash rather than generating it. Over months this erodes runway, forces reliance on funding events, and limits the ability to advance programs without dilutive or costly capital raises.
Small Recurring Revenue BaseWith only $1.16M TTM revenue, recurring cash from operations is insufficient to support ongoing R&D and property costs. The business remains dependent on nonrecurring gains, milestone payments, or external financing, a structural weakness if near-term clinical or licensing events are delayed.
Eroding Equity And Negative ROEA TTM ROE near -39% and declining equity show operating losses are eroding the capital base. This persistent deterioration reduces financial flexibility, raises the likelihood of dilutive financings, and weakens the company’s ability to absorb future setbacks over a multi-month horizon.
Rafael Holdings News
RFL FAQ
What was Rafael Holdings Inc’s price range in the past 12 months?
Rafael Holdings Inc lowest stock price was $1.12 and its highest was $3.19 in the past 12 months.
What is Rafael Holdings Inc’s market cap?
Rafael Holdings Inc’s market cap is $71.27M.
When is Rafael Holdings Inc’s upcoming earnings report date?
Rafael Holdings Inc’s upcoming earnings report date is Jun 16, 2026 which is in 26 days.
How were Rafael Holdings Inc’s earnings last quarter?
Rafael Holdings Inc released its earnings results on Mar 16, 2026. The company reported -$0.125 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.125.
Is Rafael Holdings Inc overvalued?
According to Wall Street analysts Rafael Holdings Inc’s price is currently Overvalued.
Does Rafael Holdings Inc pay dividends?
Rafael Holdings Inc pays a Semiannually dividend of $0.02 which represents an annual dividend yield of N/A. See more information on Rafael Holdings Inc dividends here
What is Rafael Holdings Inc’s EPS estimate?
Rafael Holdings Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rafael Holdings Inc have?
Rafael Holdings Inc has 51,224,976 shares outstanding.
What happened to Rafael Holdings Inc’s price movement after its last earnings report?
Rafael Holdings Inc reported an EPS of -$0.125 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.763%.
Which hedge fund is a major shareholder of Rafael Holdings Inc?
Currently, no hedge funds are holding shares in RFL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Rafael Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.51%
12-Months-Change
Fundamentals
Return on Equity
-39.03%
Trailing 12-Months
Asset Growth
19.60%
Trailing 12-Months
Company Description
Rafael Holdings Inc
Rafael Holdings, Inc. (RFL) is a biopharmaceutical company focused on advancing innovative therapies to treat cancer and other life-threatening diseases. The company operates primarily in the healthcare sector, with a core emphasis on developing and commercializing targeted drug therapies. Rafael Holdings also engages in real estate investments, which provide additional financial stability and diversification to its business model.
Technical Analysis
JW Mays
―
New England Realty Associates Partnershi
―
Fathom Holdings
―
Offerpad Solutions
―
Star Holdings
―
Ownership Overview
30.42% Insiders
3.51% Mutual Funds
0.26% Other Institutional Investors
62.93% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---